A Real-World Pharmacovigilance Study of Cilostazol Based on the Food and Drug Administration Adverse Event Reporting System: A Cross-Sectional Disproportionality Analysis.
Saved in:
| Title: | A Real-World Pharmacovigilance Study of Cilostazol Based on the Food and Drug Administration Adverse Event Reporting System: A Cross-Sectional Disproportionality Analysis. |
|---|---|
| Authors: | Zhang HY; Department of Vascular Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China., Xiao L; Department of Vascular Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China., Chen K; Department of Vascular Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China., Du XL; Department of Vascular Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China., Tang T; Department of Vascular Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China., Li WD; Department of Vascular Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China; Department of Vascular Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China. Electronic address: vasculars@126.com., Liu PC; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China. Electronic address: liupcmail@163.com., Li XQ; Department of Vascular Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China; Department of Vascular Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China. Electronic address: focus@njucm.edu.cn. |
| Source: | Annals of vascular surgery [Ann Vasc Surg] 2026 Jun; Vol. 127, pp. 391-400. Date of Electronic Publication: 2026 Feb 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8703941 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1615-5947 (Electronic) Linking ISSN: 08905096 NLM ISO Abbreviation: Ann Vasc Surg Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41713801 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Real-World Pharmacovigilance Study of Cilostazol Based on the Food and Drug Administration Adverse Event Reporting System: A Cross-Sectional Disproportionality Analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zhang+HY%22">Zhang HY</searchLink>; Department of Vascular Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Xiao+L%22">Xiao L</searchLink>; Department of Vascular Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Chen+K%22">Chen K</searchLink>; Department of Vascular Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.<br /><searchLink fieldCode="AU" term="%22Du+XL%22">Du XL</searchLink>; Department of Vascular Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Tang+T%22">Tang T</searchLink>; Department of Vascular Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China.<br /><searchLink fieldCode="AU" term="%22Li+WD%22">Li WD</searchLink>; Department of Vascular Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China; Department of Vascular Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China. Electronic address: vasculars@126.com.<br /><searchLink fieldCode="AU" term="%22Liu+PC%22">Liu PC</searchLink>; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China. Electronic address: liupcmail@163.com.<br /><searchLink fieldCode="AU" term="%22Li+XQ%22">Li XQ</searchLink>; Department of Vascular Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China; Department of Vascular Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China. Electronic address: focus@njucm.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228703941%22">Annals of vascular surgery</searchLink> [Ann Vasc Surg] 2026 Jun; Vol. 127, pp. 391-400. <i>Date of Electronic Publication: </i>2026 Feb 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8703941 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1615-5947 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208905096%22">08905096 </searchLink><i>NLM ISO Abbreviation: </i>Ann Vasc Surg <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41713801 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.avsg.2026.01.043 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 391 Titles: – TitleFull: A Real-World Pharmacovigilance Study of Cilostazol Based on the Food and Drug Administration Adverse Event Reporting System: A Cross-Sectional Disproportionality Analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhang HY – PersonEntity: Name: NameFull: Xiao L – PersonEntity: Name: NameFull: Chen K – PersonEntity: Name: NameFull: Du XL – PersonEntity: Name: NameFull: Tang T – PersonEntity: Name: NameFull: Li WD – PersonEntity: Name: NameFull: Liu PC – PersonEntity: Name: NameFull: Li XQ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1615-5947 Numbering: – Type: volume Value: 127 Titles: – TitleFull: Annals of vascular surgery Type: main |
| ResultId | 1 |